Advertisement

Topics

Latest "Stella Technology, Inc." News Stories - Page: 7

11:35 EST 15th November 2018 | BioPortfolio

Here are the most relevant search results for "Stella Technology, Inc." found in our extensive news archives from over 250 global news sources.

More Information about Stella Technology, Inc. on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Stella Technology, Inc. for you to read. Along with our medical data and news we also list Stella Technology, Inc. Clinical Trials, which are updated daily. BioPortfolio also has a large database of Stella Technology, Inc. Companies for you to search.

Showing "Stella Technology" News Articles 151–175 of 12,000+

Tuesday 13th November 2018

Amplyx doses first patient in Phase II APX001 study

Amplyx Pharmaceuticals has dosed the first patient in a Phase II clinical trial to assess the efficacy and safety of...Read More... The post Amplyx doses first patient in Phase II APX001 study appeared first on Drug Development Technology.


Sobi to buy US rights to AstraZeneca’s Synagis drug for $1.5bn

Swedish biopharmaceutical firm Swedish Orphan Biovitrum (Sobi) has signed agreements to acquire the rights to AstraZeneca’s Synagis (palivizumab) medicine in...Read More... The post Sobi to buy US rights to AstraZeneca’s Synagis drug for $1.5bn appeared first on Pharmaceutical Technology.

InvaGen to acquire Avenue Therapeutics for $215m

InvaGen Pharmaceuticals, a unit of India-based Cipla, has signed definitive agreements to buy US-based specialty pharmaceutical firm Avenue Therapeutics for...Read More... The post InvaGen to acquire Avenue Therapeutics for $215m appeared first on Pharmaceutical Technology.


Calliditas enrols first patient in Phase III study of Nefecon

Calliditas Therapeutics has enrolled the first patient in a pivotal Phase III NEFIGARD clinical trial to evaluate nefecon for the...Read More... The post Calliditas enrols first patient in Phase III study of Nefecon appeared first on Drug Development Technology.

Nightstar to start Phase II/III trial of NSR-RPGR for XLRP

Nightstar Therapeutics will begin a Phase II/III trial to investigate the safety and efficacy of NSR-RPGR for the treatment of...Read More... The post Nightstar to start Phase II/III trial of NSR-RPGR for XLRP appeared first on Drug Development Technology.

Genomic profiling offers hope for rare cancer treatments

A clinical trial led by Walter and Eliza Hall Institute of Medical Research in Australia has demonstrated that genomic profiling...Read More... The post Genomic profiling offers hope for rare cancer treatments appeared first on Pharmaceutical Technology.

'Hopeful technology' could change detection, diagnosis of deadly ovarian cancer

(Washington University in St. Louis) Ovarian cancer claims the lives of more than 14,000 women in the U.S. each year, ranking fifth among cancer deaths in women. A multidisciplinary team at Washington University has found an innovative way to use sound and light to diagnose ovarian tumors, which may lead to a promising new diagnostic imaging technique to improve current standard of care.

Activate Releases Fifth Annual Key Insights for Future of Tech Media in 2019

Disruptive Trends Reshape the Year Ahead SAN FRANCISCO and NEW YORK, Nov. 14, 2018 /PRNewswire/ -- Activate, a leading strategy and technology consulting firm for Read more...

Advanced computer technology & software turn species identification interactive

(Pensoft Publishers) Representing a group of successful biocontrol agents for various pest fruit flies, a parasitic wasp genus remains overlooked, with its most recent identification key dating back to 1969, even though many new species have been added since then. Through a recent study, published in the open access Biodiversity Data Journal, which also describes one new to science species, Swiss ...

Nu-Med Plus, Inc. Advances Blood and Plasma Transfusion Technology with New Patent

Nu-Med Plus’ Proprietary Technology Aims to Increase Longevity and Safety of Banked Blood Supply and Reduce Side Effects of Blood Transfusions

SwRI's Terry Alger honored with TAMEST O'Donnell Award

(Southwest Research Institute) Dr. Terry Alger, a director in the Powertrain Engineering Division at Southwest Research Institute (SwRI), will receive the 2019 Edith and Peter O'Donnell Award in Technology Innovation. The award, presented by The Academy of Medicine, Engineering and Science of Texas (TAMEST), recognizes Alger for his role in developing vehicle engine technologies that lower polluti...

Large areas of the Brazilian rainforest at risk of losing protection

(Chalmers University of Technology) Up to 15 million hectares of the Brazilian Amazon is at risk of losing its legal protection, according to a new study from researchers at Chalmers University of Technology and KTH Royal Institute of Technology, Sweden, and the University of Sao Paulo, Brazil. This is equivalent to more than 4 times the entire forest area of the UK.

Improved mosquito reference genome assembly produced using long-read sequencing

(Bioscribe) A new comprehensive map of mosquito DNA has been assembled using long-read sequencing technology from California-based Pacific Biosciences. The improved reference genome assembly, published in Nature, could help scientists combat the pest and infectious diseases it spreads, including Zika, dengue, chikungunya, and yellow fever.

Bureau of Economic Geology scientist recognized for greenhouse gas mitigation technology

(University of Texas at Austin) Susan Hovorka, a senior research scientist at The University of Texas at Austin, has won the Greenman Award for her significant contributions to the development of greenhouse gas control technologies.

F1 Oncology's International Affiliate, EXUMA Biotechnology, Announces Acquisition Of Strategic CAR-T Assets

Shanghai EXUMA Biotechnology to Develop Novel Solid Tumor CAR-T Programs Under Centralized Regulatory Pathway from Investigator-Initiated Studies Currently Underway in Shanghai SHANGHAI and WEST PALM BEACH, Florida, Nov. 13, 2018 /PRNewswire/ -- F1 Oncology, Inc., a

Nitric oxide-releasing technology shows potential to reduce healing time of diabetic foot ulcers

Diabetic foot ulcers can take up to 150 days to heal. A biomedical engineering team wants to reduce it to 21 days.

AngelMD Investor Group Closes Funding Round with Indago

Indago’s vision for “the operating room of the future” begins with a wireless arthroscopy device that eliminates documented safety risks and expensive consumables. DENVER (PRWEB) November 13, 2018 Arthroscopy is one of the most common procedures performed in the United States (almost 5,000 per day), yet its underlying technology has not seen significant change since the first video arthrosc...

Tandem Diabetes Care to Present at the Credit Suisse Healthcare Conference

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that Kim Blickenstaff, President and Chief Executive Officer and Leigh Vosseller, EVP and Chief Financial Officer, will present at the Credit Suisse 27th Annual Healthcare Conference on Wednesday, November 14, 2018 in Scottsdale, AZ at 1...

Quanterix to Present at the Canaccord Genuity Medical Technologies & Diagnostic Forum

Quanterix Corporation (NASDAQ:QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, today announced that Kevin Hrusovsky, Chief Executive Officer, President and Chairman of Quanterix, will present at the

Detailed Look at How Fossil Fuels Originate Could Lead to Better Energy Extraction Plans

ArticleNew research from the Massachusetts Institute of technology has mapped out in three dimensions the internal structure of kerogen.

Optimization of Alloy Materials: Diffusion Processes in Nano Particles Decoded

NewsAluminium alloys have unique material properties and are indispensable materials in aircraft manufacturing and space technology.Contrib

Global NFC POS Terminal Market Status and Outlook 20182025 [Report Updated: 13082018] Prices from USD $4000

Report SnapshotKey Content of Chapters Including and can be customized, report is a semifinished version, and it takes 4872 hours to upgradePart 1:Terminology Definition, Industry Chain,Industry Dynamics Regulations and Global Market OverviewPart 2:Upstream Raw Materials / Components Manufacturing Procurement Methods Channels and Cost , Major Regional Production Overview and Trade FlowPart 3:Pr...

Foot Ulcers Healed Quickly with Nitric Oxide Technology

NewsDiabetic foot ulcers can take up to 150 days to heal. A biomedical engineering team wants to reduce it to 21 days.

Pressure Helps to Make Better Li-Ion Batteries

NewsRechargeable Li-ion batteries are crucial parts for home electronics and portable devices such as cell phones and laptops. Contributed Author: 

Clearskincare Cites Flexible Reporting Features For Switch to Zenoti

Clearskincare, Australia’s leading acne, skin and laser clinic, has chosen Zenoti as their technology provider for their network of 45 clinics in Australia and New Zealand. BELLEVUE, Wash. (PRWEB) November 13, 2018 Clearskincare, Australia’s leading acne, skin and laser clinic, has chosen Zenoti as their technology provider for their network of 45 clinics in Australia and New Zealand. Chief a...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks